Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
The American Journal of Pathology|August 16, 2017
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular CancerElisabetta Puliga, Qian Min, Junyan Tao, et al.Journal of Wuhan University of Technology. Materials Science Edition|September 6, 2021
PDLLA/β-TCP/HA/CHS/NGF Sustained-release Conduits for Peripheral Nerve RegenerationXiumei Yan, Jing Wang, Qundi He, et al.Oncotarget|March 14, 2019
mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and developmentLaura Molina, Hong Yang, Adeola O Adebayo Michael, et al.Oncotarget|March 13, 2015
Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancerJunyan Tao, Junfang Ji, Xiaolei Li, et al.Environmental Science and Pollution Research International|February 11, 2023
Embryonic benzophenone-3 exposure inhibited fertility in later-life female zebrafish and altered developmental morphology in offspring embryosJunyan Tao, Qinyuan Yang, Min Jing, et al.Hepatology (Baltimore, Md.)|April 21, 2016
Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-cateninJunyan Tao, Emily Xu, Yifei Zhao, et al.Plos One|October 3, 2012
Bmi1 is required for hepatic progenitor cell expansion and liver tumor developmentLingling Fan, Chuanrui Xu, Chunmei Wang, et al.International Journal of Molecular Sciences|November 14, 2020
Pivotal Role of Fatty Acid Synthase in c-MYC Driven HepatocarcinogenesisJiaoyuan Jia, Li Che, Antonio Cigliano, et al.Hepatology Communications|March 18, 2024
Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editingMuhamuda Kader, Wei Sun, Bao-Guo Ren, et al.The American Journal of Pathology|June 20, 2018
Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in HepatoblastomaLaura Molina, Danielle Bell, Junyan Tao, et al.Pageof 10